Cargando…
Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
The clinical application of doxorubicin (DOX) is compromised by its cardiac toxic effect. Cyclovirobuxine D (CVB-D) is a steroid alkaloid extracted from a traditional Chinese medicine, Buxus microphylla. Our results showed that CVB-D pretreatment markedly attenuated DOX-induced cardiac contractile d...
Autores principales: | Guo, Qian, Guo, Jiabin, Yang, Rong, Peng, Hui, Zhao, Jun, Li, Li, Peng, Shuangqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446494/ https://www.ncbi.nlm.nih.gov/pubmed/26075032 http://dx.doi.org/10.1155/2015/151972 |
Ejemplares similares
-
Zinc Oxide Nanoparticles Induce Mitochondrial Biogenesis Impairment and Cardiac Dysfunction in Human iPSC-Derived Cardiomyocytes
por: Li, Yujie, et al.
Publicado: (2020) -
Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin
por: Zhang, Lin, et al.
Publicado: (2021) -
Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro
por: Gao, Ge, et al.
Publicado: (2022) -
Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020) -
Cyclovirobuxine D pretreatment ameliorates septic heart injury through mitigation of ferroptosis
por: Wang, Jianxin, et al.
Publicado: (2023)